Get the Stockscreener App
5.28
4.17%
-0.23
Quanterix Corp stock is traded at $5.28, with a volume of 348.16K.
It is down -4.17% in the last 24 hours and down -5.55% over the past month.
Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.
See More
Previous Close:
$5.51
Open:
$5.65
24h Volume:
348.16K
Relative Volume:
0.49
Market Cap:
$233.51M
Revenue:
$121.14M
Net Income/Loss:
$-32.33M
P/E Ratio:
-6.1395
EPS:
-0.86
Net Cash Flow:
$-22.69M
1W Performance:
-12.22%
1M Performance:
-5.55%
6M Performance:
-65.03%
1Y Performance:
-69.16%
1-Day Range:
$5.26
$5.65
1-Week Range:
$5.21
$6.01
52-Week Range:
$4.67
$19.18
Quanterix Corp Stock (QTRX) Company Profile
Name
Quanterix Corp
Sector
Industry
Phone
617-301-9400
Address
900 MIDDLESEX TURNPIKE, BILLERICA, MA
Compare QTRX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
QTRX
Quanterix Corp
|
5.28 | 233.51M | 121.14M | -32.33M | -22.69M | -0.86 |
|
ABT
Abbott Laboratories
|
133.24 | 231.09B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.86 | 155.24B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
380.92 | 144.54B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.48 | 108.82B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
73.68 | 44.31B | 5.54B | 4.18B | 623.10M | 7.00 |
Quanterix Corp Stock (QTRX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-01-24 | Initiated | Scotiabank | Sector Outperform |
| Sep-25-23 | Upgrade | Canaccord Genuity | Hold → Buy |
| Aug-08-23 | Upgrade | SVB Securities | Market Perform → Outperform |
| May-23-23 | Upgrade | Goldman | Neutral → Buy |
| Aug-15-22 | Downgrade | Canaccord Genuity | Buy → Hold |
| Aug-09-22 | Downgrade | Cowen | Outperform → Market Perform |
| Aug-09-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Mar-02-22 | Upgrade | Goldman | Sell → Neutral |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Jun-04-21 | Initiated | Goldman | Sell |
View All
Quanterix Corp Stock (QTRX) Latest News
Quanterix Corp expected to post a loss of 44 cents a shareEarnings Preview - TradingView
53,626 Shares in Quanterix Co. (NASDAQ:QTRX) Acquired by Raymond James Financial Inc. - Defense World
MetLife Investment Management LLC Has $255,000 Position in Quanterix Co. (NASDAQ:QTRX) - Defense World
NewGenIVF Introduces NewGenSort to Support Men’s Reproductive Health Across Asia - Stock Titan
Invesco Ltd. Acquires 4,729 Shares of Quanterix Co. (NASDAQ:QTRX) - Defense World
Barclays PLC Reduces Holdings in Quanterix Co. (NASDAQ:QTRX) - Defense World
Wells Fargo & Company MN Cuts Stock Position in Quanterix Co. (NASDAQ:QTRX) - Defense World
Quanterix Co. (NASDAQ:QTRX) Receives $16.20 Average Target Price from Brokerages - Defense World
Quanterix’s (QTRX) Market Perform Rating Reiterated at Leerink Partners - Defense World
Quanterix Corp (QTRX) can make a big difference with a little luck - Sete News
It would be worthwhile to take a closer look at Quanterix Corp (QTRX) - uspostnews.com
Investor’s Delight: Quanterix Corp (QTRX) Closes Strong at 6.05, Up 4.67 - DWinneX
Quanterix Corp [QTRX] Investment Guide: What You Need to Know - knoxdaily.com
Acquisition price for Marlborough biotech slashed - The Business Journals
Quanterix, Akoya Biosciences Amend Merger Deal - marketscreener.com
Quanterix And Akoya Biosciences Announce Amended Merger Agreement - marketscreener.com
Quanterix revises merger terms with Akoya Biosciences - Investing.com
$HAREHOLDER ALERT: The M&A Class Action Firm Urges Stockholders of AKYA, WTMA, PLYA, QTRX to Act Now - GlobeNewswire Inc.
Quanterix Co. (NASDAQ:QTRX) Shares Bought by Envestnet Asset Management Inc. - Defense World
Insider Buying: WALT DAVID R, Quanterix Corp [QTRX] Director invested 47,000 shares - knoxdaily.com
Quanterix Corp (QTRX) looking to reclaim success with recent performance - Sete News
Geode Capital Management LLC Raises Position in Quanterix Co. (NASDAQ:QTRX) - Defense World
Market Resilience: Quanterix Corp (QTRX) Finishes Strong at 5.16, Up 5.52 - DWinneX
A stock that deserves closer examination: Quanterix Corp (QTRX) - uspostnews.com
JPMorgan Chase & Co. Raises Stock Position in Quanterix Co. (NASDAQ:QTRX) - Defense World
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RKDA, CKPT, QTRX on Behalf of Shareholders - marketscreener.com
QUANTERIX CORP : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Change in Directors or Principal Officers (form 8-K) - marketscreener.com
Kent Lake Files Definitive Proxy Statement And Sends Letter To Quanterix Shareholders - marketscreener.com
Kent Lake Files Definitive Proxy Statement and Sends Letter to Quanterix Shareholders - marketscreener.com
Quanterix Co. (NASDAQ:QTRX) Shares Purchased by Vanguard Group Inc. - Defense World
Tikvah Management Calls on Quanterix to Explain the Egregious Te - GuruFocus
Tikvah Management Calls on Quanterix to Explain the Egregious Terms of Convertible Notes Purchased from Akoya Biosciences - Bluefield Daily Telegraph
Quanterix Faces Investor Backlash: $30M Convertible Notes Deal Under Fire - Stock Titan
American Century Companies Inc. Grows Stock Position in Quanterix Co. (NASDAQ:QTRX) - Defense World
KLP Kapitalforvaltning AS Takes $66,000 Position in Quanterix Co. (NASDAQ:QTRX) - Defense World
Quanterix stock plunges to 52-week low of $4.85 amid market challenges - Investing.com
Raymond James Financial Inc. Purchases New Position in Quanterix Co. (NASDAQ:QTRX) - Defense World
Kent Lake Comments on Quanterix?s Bridge Financing for Akoya - MarketScreener
Quanterix Under Fire: Top Investor Warns of 'Value Destructive' $30M Deal with Struggling Akoya - Stock Titan
Quanterix: Still Many, Many Questions - Seeking Alpha
Quanterix Showcases Innovation Powered by Simoa® at AD/PD with Customer Research and New Dried Blood Spot Extraction Kit - Yahoo Finance
Revolutionary Blood Spot Kit Makes Alzheimer's Testing More Accessible and Affordable - Stock Titan
Quanterix Co. (NASDAQ:QTRX) Sees Large Decline in Short Interest - MarketBeat
Quanterix stock plunges to 52-week low at $6.27 amid market challenges - Investing.com
Quanterix CorpOn March 24, Appointed William P. Donnelly As ChairmanSEC Filing - MarketScreener
Charles Schwab Investment Management Inc. Sells 58,989 Shares of Quanterix Co. (NASDAQ:QTRX) - Defense World
Scotiabank cuts Quanterix stock price target to $18 from $28 By Investing.com - Investing.com Australia
Quanterix (NASDAQ:QTRX) Given New $18.00 Price Target at Scotiabank - Defense World
Scotiabank cuts Quanterix stock price target to $18 from $28 - Investing.com India
Bank of New York Mellon Corp Has $1.15 Million Stake in Quanterix Co. (NASDAQ:QTRX) - Defense World
Tikvah to oppose Quanterix-Akoya Biosciences merger By Investing.com - Investing.com Australia
Quanterix Corp Stock (QTRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.11%
0.79%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):